Evidence map›Paper›PMID 29713321›Full record

ArticleFrontiers in immunology2018

Johanna Salvermoser, Janneke van Blijswijk, Nikos E Papaioannou, Stephan Rambichler, Maria Pasztoi, Dalia Pakalniškytė, Neil C Rogers, Selina J Keppler, Tobias Straub, Caetano Reis e Sousa and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. RORγtScience immunology · 2026
    Article
  3. Review
  4. Review
  5. Thymic Dendritic Cells Revisited.Immunological reviews · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The emerging family of RORγtNature reviews. Immunology · 2024
    Review
  13. Article
  14. Article
  15. Ly6DNature communications · 2022
    Article
  16. Selective depletion of a CD64-expressing phagocyte subset mediates protection against toxic kidney injury and failure.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Article
  18. Article
  19. Generation of PECAM-1 (CD31) conditional knockout mice.Genesis (New York, N.Y. : 2000) · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Johanna SalvermoserWalter-Brendel-Centre for Experimental Medicine, University Hospital, LMU Munich, Planegg Martinsried, Germany.
Janneke van BlijswijkImmunobiology Laboratory, The Francis Crick Institute, London, United Kingdom.
Nikos E PapaioannouBiomedical Center, LMU Munich, Planegg Martinsried, Germany.
Stephan RambichlerWalter-Brendel-Centre for Experimental Medicine, University Hospital, LMU Munich, Planegg Martinsried, Germany.
Maria PasztoiBiomedical Center, LMU Munich, Planegg Martinsried, Germany.
Dalia PakalniškytėWalter-Brendel-Centre for Experimental Medicine, University Hospital, LMU Munich, Planegg Martinsried, Germany.
Neil C RogersImmunobiology Laboratory, The Francis Crick Institute, London, United Kingdom.
Selina J KepplerTechnische Universität München, Klinikum Rechts der Isar, Institut für Klinische Chemie und Pathobiochemie, Munich, Germany.
Tobias StraubBiomedical Center, LMU Munich, Planegg Martinsried, Germany.
Caetano Reis e SousaImmunobiology Laboratory, The Francis Crick Institute, London, United Kingdom.
Barbara U SchramlWalter-Brendel-Centre for Experimental Medicine, University Hospital, LMU Munich, Planegg Martinsried, Germany.
Ludwig-Maximilians-Universität München · DEThe Francis Crick Institute · GBUrologische Klinik München · DEMünchen Klinik · DE

Funding

Medical Research Council FC001136Wellcome Trust FC001136
6 · The paper itself

Abstract

Conventional dendritic cells (cDCs) are versatile activators of immune responses that develop as part of the myeloid lineage downstream of hematopoietic stem cells. We have recently shown that in mice precursors of cDCs, but not of other leukocytes, are marked by expression of DNGR-1/CLEC9A. To genetically deplete DNGR-1-expressing cDC precursors and their progeny, we crossed

Indexed as

AnimalsDendritic CellsDiphtheria ToxinLectins, C-TypeMiceReceptors, ImmunologicClec9a protein, mouseDiphtheria ToxinLectins, C-TypeReceptors, ImmunologicCLEC9A/DNGR-1DC depletiondendritic celldevelopmentfate mappinglymphopoiesismyelopoiesis

Identifiers

PMID29713321
PMCPMC5911463
OpenAlexW2802011129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.